8 – 11 November 2022

• Oral abstract session
• E-poster session

This year’s conference will be virtual. Oral abstract and e-poster presentations will be pre-recorded in September and uploaded via a dedicated conference platform. Technical specifications will be provided at a later stage to help speakers prepare.

• For oral abstract sessions, presenters will be required to attend (be online/participate in) the broadcast of their presentation during the virtual conference and participate in the live discussion that will take place at the close of each abstract session.
• E-poster presenters will be required to address written comments and questions which may be raised on their e-poster in the virtual conference platform during the conference. This will not be a live interaction so presenters can choose to do this in their time zone during conference days.

Please select the most appropriate track. Note this is to assist with programme planning. Track choice has no impact on the selection process.

The list of tracks are available here.

Please type the title of the abstract in upper and lower case, using capitals only for the first word, acronyms and proper nouns. Titles of more than 25 words (110 characters and spaces) will be truncated.

Please provide a 50-word summary of your abstract for publication on the online programme, prior to the lifting of the conference embargo. This should not include any results but should provide information of relevance to assist delegates in selecting sessions of interest.

·       The abstract text should not exceed 300 words. Abstracts of more than 300 words will be truncated.

·       Please note that affiliations don’t count as part of the 300 words. Abstracts must be submitted in English only. No simultaneous interpretation will be provided for the conference.

·       Use the formatting options provided to insert symbols, accents and special formatting (e.g., italics, bold, β, μ, etc.).

·       Authors are responsible for proofreading and submitting an abstract without errors, as they will be reproduced in the form they were submitted.

·       Abbreviations and acronyms must be written out in full at the first mention in the text.

The 2021 Conference Abstract Book is available here for your reference.

All submitters can choose out of two abstract categories:

Category 1: Scientific Research

This category is for reporting scientific and public health evaluations as well as operational research. Abstracts in Category 1 should be organised as follows:

– Background: State the study objectives, study question/hypothesis or describe the challenge addressed by the research.
– Design/Methods: Describe study design, setting, desired outcomes, procedures and techniques used to collect and analyse data. Include a description of appropriate statistical analysis.
– Results: Present specific findings to date.
– Conclusions: Describe the implications of the results presented and summarise key recommendations. Explain specific findings on how the research addressed the study question or challenge.

Category 2: Public Health Practice

This category is for reporting experiences in overcoming policy or programme barriers and demonstrating best practices in implementing effective prevention and control programming. This includes identification of service delivery issues and the presentation of evidence-based practices that programmes have adopted. Abstracts in Category 2 should be organised as follows:

– Background and challenges to implementation: Identify the context and the specific challenges to programme implementation.
– Intervention or response: How was the challenge overcome? Detail the methods, activities and implementation steps used to overcome the challenge. Describe the procedures and techniques used to collect and analyse information that informed your conclusions.
– Results/Impact: Describe the results and impact of the project. Explain the potential application or benefit to other programmes. Define what worked, what did not work and the evidence that led to this determination.
– Conclusions: Describe the public health practice implications of the results and summarise key recommendations. Highlight opportunities for future programme practice and implications for other programmes or setting

• Authors may submit one table or one figure per abstract. If more than one table or figure are submitted, one of them will be deleted.
• Tables should be smaller than 10 rows x 10 columns.

• If you wish to submit a figure/image with your abstract, click on the “Insert Image” icon .
• The maximum file size of each figure/image is 5 MB. The maximum pixel size of the figure/image is 600(w) x 800(h) pixels.
• You may upload graphs in JPG, GIF or PNG format.
• The graphic content must be clearly legible when previewing the abstract.
• Recommended resolution: min. 150 dpi, 300 dpi for images, 600 dpi for line art (charts). Low-resolution images will not be included in the Abstract Book.
• Please do not upload the text of your abstract as an attachment. Uploaded abstracts will not be considered.
• Please note that tables and figures are reproduced in a single column with the abstract and that legibility is the responsibility of the author. We recommend that you use a sans serif (Arial or Calibri) font for clarity.

• A maximum of 12 authors will be allowed.
• If all authors belong to a single institution, you do not need to create new affiliations for each author. Click on “Institutes” to prefill the form.
• The corresponding author is responsible for the abstract content. S/he is the contact person for submission and communication purposes and is also responsible for disseminating information related to the abstract to the co-authors.
• A listed co-author other than the corresponding author may register and present the study at the conference.
• Once the abstract is submitted and reviewed, the list of co-authors can no longer be amended. Please make sure there is no oversight in the final list of co-authors before proceeding with the submission.

A biography of no more than 100 words must be submitted by the proposed presenter.

All submitted abstracts will be sent for peer review to a panel of international experts in the fields of TB, adult & child lung health, HIV and tobacco control. Each abstract will be reviewed and scored by at least three reviewers. The scores will then be submitted to the members of the Coordinating Committee of Scientific Activities (CCSA), who will determine which abstracts are accepted and whether they are best suited for oral abstract presentation sessions or e-poster sessions.

• Corresponding authors will be notified of the status of their abstracts by the end of June. Please make sure you inform the co-authors of the submission status of your abstract.
• If your abstract has been allocated to a specific session, please note that it will not be possible to change the date, time or type of session. Any allocation is final. A co-author or colleague can present on your behalf if you are not available on the assigned date and time.
• Abstracts that are not accepted cannot be reconsidered for review or presentation at the conference.